HypertensionNCT06247111

Monitoring Blood Pressure at Home

A study testing Remote Blood Pressure Monitoring + Telehealth in people with Hypertension, run by University of Alabama at Birmingham at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record

Search all trials

Trial summary

Who is it for?: Ages 18 years and older
Conditions the study is for: Hypertension
What is being tested?: Remote Blood Pressure Monitoring + Telehealth
Could I receive a placebo?: Yes, some participants may receive a placebo
How many people: 24 participants
Where: 1 siteUnited States
Study dates: 10 Jul 2024to Dec 2026
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Who may be able to join

Patients seen at the Emergency Department Post-Discharge Clinic
>=18 years
Blood pressure >=130/80 mmHg and <=160/100 mmHg
English speakers
Have a smartphone

Who cannot join

Patients with blood pressure >=160 mmHg

Trial locations and contacts

1 site in 1 country.

United States1 site

University of Alabama at Birmingham
Birmingham, Alabama, 35294

Other trials in United States

About this study

Official title: Post-Emergency Department Discharge Clinic Telehealth Program for Patients With Uncontrolled Hypertension: a Pilot Study

The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage your blood pressure is feasible. The study will enroll 24 participants at UAB who are seen at the Emergency Department Post-Discharge Clinic. Half of the participants (12 patients) will be asked to measure their blood pressure at home, and half of the participants (12 patients) will continue to receive usual care. Participants who measure their blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 3 months.

Read the detailed description

For all participants:

Participants will receive information on the importance of measuring blood pressure and ways to improve blood pressure.
Participants will complete questionnaires describing current socioeconomic position, medical history and healthcare needs.
Participants will come in for one research clinic visit to get blood pressure measured 3 months after enrollment in this study.

For participants asked to measure blood pressure at home:

Measure blood pressure twice a day at home, following the instructions provided. The study will provide participants with the device and send text message reminders each week day. Participants will return the device at study visit 3 months from now.
Following the instructions provided, participants will talk to a pharmacist over the phone weekly to discuss blood pressure and medications. All medication changes will be discussed with a collaborating physician.
Participants will complete questionnaires on satisfaction with the program.

Conditions: Hypertension
Being tested: Remote Blood Pressure Monitoring + Telehealth, Usual care
Keywords: hypertension, blood pressure
Medical subject headings: Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Remote Blood Pressure Monitoring + TelehealthOther
Remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
Usual careOther
Participants receive usual care, no intervention.

Study groups in NCT06247111
Study group	Role	What they receive
Usual Care	Placebo comparator	Participants receive usual care from providers to manage their blood pressure Receives: Other: Usual care
Remote Blood Pressure Monitoring + Telehealth	Active comparator	Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management Receives: Other: Remote Blood Pressure Monitoring + Telehealth

What is being measured

The primary outcome is the main question the study is designed to answer.

Total Number of Recruited Participants
Number of participants enrolled into the study after screening and eligibility confirmation.
Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

10 Jul 2024Dec 2026

First posted7 Feb 2024
Study start10 Jul 2024
Primary completion1 May 2025
Study completionDec 2026 (estimated)

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Other trials for HypertensionStudies of the same condition, open and under way.
More trials run by University of Alabama at BirminghamThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Treatment
Allocation: Randomised
Intervention model: Parallel groups
Masking: None (open label)
Enrolment: 24 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT06247111
Sponsor's protocol ID: IRB-300012428
Other IDs: P50MD017338
Status last verified: Mar 2026
First submitted: 30 Jan 2024
Last updated: 29 Apr 2026
Results posted: Yes, on ClinicalTrials.gov
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension

All Hypertension trials

Study at a glance

From the registry record, last updated by the sponsor on 29 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Post-Emergency Department Discharge Clinic Telehealth Program for Patients With Uncontrolled Hypertension: a Pilot Study
ClinicalTrials.gov ID: NCT06247111
Acronym / sponsor ID: IRB-300012428
Conditions: Hypertension
Keywords: hypertension, blood pressure
Study type: Interventional
Recruitment status: Active, not recruiting
Enrolment: 24 participants (actual)
Lead sponsor: University of Alabama at BirminghamUniversity, hospital or other
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Study start: 10 Jul 2024 (actual)
Primary completion: 1 May 2025 (actual)
Study completion: Dec 2026 (estimated)
First posted: 7 Feb 2024 (actual)
Results: Posted 29 Apr 2026

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Detailed description

For all participants:

Participants will receive information on the importance of measuring blood pressure and ways to improve blood pressure.
Participants will complete questionnaires describing current socioeconomic position, medical history and healthcare needs.
Participants will come in for one research clinic visit to get blood pressure measured 3 months after enrollment in this study.

For participants asked to measure blood pressure at home:

Measure blood pressure twice a day at home, following the instructions provided. The study will provide participants with the device and send text message reminders each week day. Participants will return the device at study visit 3 months from now.
Following the instructions provided, participants will talk to a pharmacist over the phone weekly to discuss blood pressure and medications. All medication changes will be discussed with a collaborating physician.
Participants will complete questionnaires on satisfaction with the program.

Study design

Primary purpose: Treatment
Allocation: Randomised
Intervention model: Parallel groups
Masking: None (open label)
Number of arms: 2

Arm	Type	Receives
Usual Care	Placebo comparator	Other: Usual careParticipants receive usual care from providers to manage their blood pressure
Remote Blood Pressure Monitoring + Telehealth	Active comparator	Other: Remote Blood Pressure Monitoring + TelehealthParticipants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult

Key inclusion criteria (5 listed)

Patients seen at the Emergency Department Post-Discharge Clinic
>=18 years
Blood pressure >=130/80 mmHg and <=160/100 mmHg
English speakers
Have a smartphone

Key exclusion criteria (1 listed)

Patients with blood pressure >=160 mmHg

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Remote Blood Pressure Monitoring + TelehealthRemote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management	Other	Remote Blood Pressure Monitoring + Telehealth
Usual careParticipants receive usual care, no intervention.	Other	Usual Care

Primary outcome

Total Number of Recruited Participants
Time frame: 2 years
Number of participants enrolled into the study after screening and eligibility confirmation.

Results and safety

Results posted to the registry on 29 Apr 2026, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
Usual Care	12	8
Intervention	12	8

Primary outcome: Total Number of Recruited Participants

Time frame: 2 years. Count of participants. Unit: Participants

Measure	All Participants n = 27
Value	24

Population analysed: Overall Number of Participants Analyzed represents the number of participants screened for study interest prior to enrollment. Of 27 screened, 24 were eligible and successfully enrolled.

Adverse events

Time frame: 3 months. Other adverse events reported at 0% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
Usual Care	0 of 12 (0%)	0 of 12 (0%)	0 of 12
Remote Blood Pressure Monitoring + Telehealth	0 of 12 (0%)	0 of 12 (0%)	0 of 12

Limitations and caveats (from the sponsor): This study was a small single-center pilot randomized study designed to evaluate feasibility of recruitment and retention for a remote blood pressure monitoring and pharmacist-led telehealth program. The study was not powered to evaluate clinical effectiveness of the intervention. In addition, follow-up was limited to three months and not all participants completed the final study visit.

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2026.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Individual participant dataSharing planned: No

Related trials for Hypertension

Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Lama Ghazi, MD, PhD principal investigator

University of Alabama at Birmingham

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Remote Blood Pressure Monitoring + Telehealth in people with Hypertension, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 29 Apr 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total Number of Recruited Participants (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06247111.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.